Another recent study showed that CD34-expressing (a carcinoma stem cell (CSC) marker) cells, residing in DMBA/TPA-induced skin tumors, formed secondary tumors upon transplantation into immunodeficient mice [43]. The gene discussed is CD34; the disease is carcinoma.